Church-based Health Intervention for Cardiovascular Disease
(CHERISH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two methods to reduce heart disease risk in predominantly Black communities in New Orleans. One strategy involves group education sessions, while the other uses community health workers for personal coaching and support. The researchers aim to determine which approach more effectively improves heart health by following evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD. Suitable participants have three or more heart disease risk factors, such as smoking, being overweight, or having high blood pressure. Participants should be connected to participating churches and live in the New Orleans area. As an unphased trial, this study offers a unique opportunity to contribute to community health improvements and potentially benefit from personalized heart health strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the treatments in this trial adhere to the 2019 ACC/AHA guidelines for preventing heart disease. These guidelines emphasize that a healthy lifestyle is the safest and most effective way to prevent heart problems.
The treatments involve education on healthy living and heart health management, such as proper nutrition and monitoring blood pressure. These methods are generally easy to follow and safe, as they prioritize lifestyle changes over medications. No major side effects have been reported from adhering to these guidelines.
In summary, the treatments in this trial focus on lifestyle changes and are safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores new strategies for preventing cardiovascular disease within church communities. Unlike standard medical treatments that often involve medications or clinical settings, these interventions leverage community-based education and support. The group-based education strategy offers sessions that teach self-monitoring of blood pressure and connect participants with primary care physicians. Meanwhile, the community health worker-led approach provides personalized coaching, navigation through healthcare systems, and integrates nutrition and exercise programs within church settings. These community-focused methods aim to make heart health management more accessible and supportive, potentially leading to better adherence and outcomes.
What evidence suggests that this trial's treatments could be effective for cardiovascular disease?
This trial will compare two strategies for preventing cardiovascular disease. Research has shown that community programs, such as the group-based education sessions in this trial, can enhance knowledge about heart disease and promote healthier habits, like improved diet and increased exercise. These programs have increased physical activity and reduced heart disease risk factors over time.
Another strategy in this trial involves implementation led by community health workers (CHWs). Studies indicate that CHWs can significantly reduce heart disease risk and encourage healthy behaviors. By providing personalized support and advice, CHWs have effectively helped individuals manage their heart disease risk. Both methods in this trial aim to reduce health disparities and improve heart health in communities, particularly among Black adults who face a higher risk.678910Are You a Good Fit for This Trial?
The CHERISH study is for Black or African American adults aged 40 and over who are connected to participating churches in New Orleans. They must have at least four of these risk factors: smoking, obesity, low physical activity, poor diet, high cholesterol, high blood pressure, or elevated blood sugar. Those with recent severe health issues like cancer treatment or heart failure aren't eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Participants receive a CHW-led multifaceted intervention or a group-based education strategy to address CVD risk factors
Follow-up
Participants are monitored for sustainability of the intervention and maintenance of cardiovascular health metrics
What Are the Treatments Tested in This Trial?
Interventions
- Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD
Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD is already approved in United States for the following indications:
- Primary prevention of cardiovascular disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tulane University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator